Pieter Jelle Visser

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

K. Blennow, J. Molinuevo, P. Scheltens, 2019, Alzheimer's & Dementia.

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology

R. Dobson, K. Blennow, J. Molinuevo, 2020, Journal of Alzheimer's disease : JAD.

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer's disease patients reveals five molecular subtypes with distinct genetic risk profiles.

F. Barkhof, P. Visser, Y. Pijnenburg, 2023, medRxiv.